Amino N - Search Results

1

Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade.

Nakao S, Arai Y, Tasaki M, Yamashita M, Murakami R, Kawase T, Amino N, Nakatake M, Kurosaki H, Mori M, Takeuchi M, Nakamura T. Nakao S, et al. Among authors: amino n. Sci Transl Med. 2020 Jan 15;12(526):eaax7992. doi: 10.1126/scitranslmed.aax7992. Sci Transl Med. 2020. PMID: 31941828

2

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

Nakahara T, Kita A, Yamanaka K, Mori M, Amino N, Takeuchi M, Tominaga F, Hatakeyama S, Kinoyama I, Matsuhisa A, Kudoh M, Sasamata M. Nakahara T, et al. Among authors: amino n. Cancer Res. 2007 Sep 1;67(17):8014-21. doi: 10.1158/0008-5472.CAN-07-1343. Cancer Res. 2007. PMID: 17804712

3

YM753, a novel histone deacetylase inhibitor, exhibits antitumor activity with selective, sustained accumulation of acetylated histones in tumors in the WiDr xenograft model.

Shindoh N, Mori M, Terada Y, Oda K, Amino N, Kita A, Taniguchi M, Sohda KY, Nagai K, Sowa Y, Masuoka Y, Orita M, Sasamata M, Matsushime H, Furuichi K, Sakai T. Shindoh N, et al. Among authors: amino n. Int J Oncol. 2008 Mar;32(3):545-55. Int J Oncol. 2008. PMID: 18292931

4

Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models.

Nakahara T, Kita A, Yamanaka K, Mori M, Amino N, Takeuchi M, Tominaga F, Kinoyama I, Matsuhisa A, Kudou M, Sasamata M. Nakahara T, et al. Among authors: amino n. Cancer Sci. 2011 Mar;102(3):614-21. doi: 10.1111/j.1349-7006.2010.01834.x. Epub 2011 Jan 12. Cancer Sci. 2011. PMID: 21205082 Free article.

5

Combination of YM155, a survivin suppressant, with bendamustine and rituximab: a new combination therapy to treat relapsed/refractory diffuse large B-cell lymphoma.

Kaneko N, Mitsuoka K, Amino N, Yamanaka K, Kita A, Mori M, Miyoshi S, Kuromitsu S. Kaneko N, et al. Among authors: amino n. Clin Cancer Res. 2014 Apr 1;20(7):1814-22. doi: 10.1158/1078-0432.CCR-13-2707. Epub 2014 Jan 31. Clin Cancer Res. 2014. PMID: 24486595

6

Blockade of EP4 by ASP7657 Modulates Myeloid Cell Differentiation In Vivo and Enhances the Antitumor Effect of Radiotherapy.

Nishibata T, Amino N, Tanaka-Kado R, Tsujimoto S, Kawashima T, Konagai S, Suzuki T, Takeuchi M. Nishibata T, et al. Among authors: amino n. Biomed Res Int. 2023 Nov 28;2023:7133726. doi: 10.1155/2023/7133726. eCollection 2023. Biomed Res Int. 2023. PMID: 38058393 Free PMC article.

7

Combination with oxaliplatin improves abscopal effect of oncolytic virotherapy through reorganization of intratumoral macrophages.

Tomita K, Yamashita M, Ikegami K, Shimizu Y, Amino N, Nakao S. Tomita K, et al. Among authors: amino n. Mol Ther. 2025 Jan 8;33(1):401-414. doi: 10.1016/j.ymthe.2024.12.007. Epub 2024 Dec 10. Mol Ther. 2025. PMID: 39663702 Free article.

8

YM-201627: an orally active antitumor agent with selective inhibition of vascular endothelial cell proliferation.

Amino N, Ideyama Y, Yamano M, Kuromitsu S, Tajinda K, Samizu K, Matsuhisa A, Kudoh M, Shibasaki M. Amino N, et al. Cancer Lett. 2006 Jul 8;238(1):119-27. doi: 10.1016/j.canlet.2005.06.037. Epub 2005 Aug 10. Cancer Lett. 2006. PMID: 16095812

9

YM-231146, a novel orally bioavailable inhibitor of vascular endothelial growth factor receptor-2, is effective against paclitaxel resistant tumors.

Amino N, Ideyama Y, Yamano M, Kuromitsu S, Tajinda K, Samizu K, Matsuhisa A, Shirasuna K, Kudoh M, Shibasaki M. Amino N, et al. Biol Pharm Bull. 2005 Nov;28(11):2096-101. doi: 10.1248/bpb.28.2096. Biol Pharm Bull. 2005. PMID: 16272696 Free article.

10

YM-359445, an orally bioavailable vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor, has highly potent antitumor activity against established tumors.

Amino N, Ideyama Y, Yamano M, Kuromitsu S, Tajinda K, Samizu K, Hisamichi H, Matsuhisa A, Shirasuna K, Kudoh M, Shibasaki M. Amino N, et al. Clin Cancer Res. 2006 Mar 1;12(5):1630-8. doi: 10.1158/1078-0432.CCR-05-2028. Clin Cancer Res. 2006. PMID: 16533791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

538 results

Search Page

Filters